Furthermore, at the transcriptional level, negative regulation of TRAIL-R1 promotor by GLI3 as well as miR-25-dependent decrease of TRAIL-R1 levels were reported for cholangiocarcinoma cells [38, 39]. Here, GLI3 is linked to cholangiocarcinoma.